Shaun Debold

Shaun Debold is a professional with expertise in biosafety, regulatory compliance, biology/bioprocessing, business development, revenue growth, public speaking, and large account management.

Shaun is dedicated to accelerating patient access to gene therapy research by expediting Institutional Biosafety Committee (IBC) reviews.

With a background in electrical and electronics engineering from Boston University, Shaun has held key roles in organizations like Advarra, Fresenius Kabi, and Abbott Point of Care.

He is known for his exceptional public speaking skills and engagement with pharmaceutical sponsors, CROs, and healthcare providers to facilitate the process of using externally administered IBCs.

Shaun's critical skillsets also include financial analysis, process control, and workflow analysis, making him a well-rounded professional in the healthcare, life sciences, and biomanufacturing sectors.

His extensive experience ranges from sales and account management to providing regulatory compliance services and involvement in GMP manufacturing facilities, demonstrating a versatile background in the industry.

Shaun's technical proficiency extends to popular business applications like Microsoft Office Suite, Salesforce.com, and various communication platforms.

An avid patient advocate, Shaun Debold is a competent individual who excels in engaging with professionals across different levels and disciplines within the healthcare sector.